You are viewing the site in preview mode

Skip to main content

Advertisement

Figure 4 | BMC Health Services Research

Figure 4

From: Cost utility analysis of reduced intensity hematopoietic stem cell transplantation in adolescence and young adult with severe thalassemia compared to hypertransfusion and iron chelation program

Figure 4

Probabilistic sensitivity analysis of the incremental costs and effectiveness (QALYs) for RI-HSCT vs BT-ICT presented on a cost-effectiveness plane. RI-HSCT: Reduced intensity hematopoietic stem cell transplantation; BT-ICT: Blood transfusion combined with iron chelating therapy; QALYs: quality adjusted life-years.

Back to article page